sunitinib accord
accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Środki przeciwnowotworowe - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.
sunitinib sandoz 12,5 mg kapsułki twarde
sandoz gmbh - sunitinibum - kapsułki twarde - 12,5 mg
sunitinib sandoz 25 mg kapsułki twarde
sandoz gmbh - sunitinibum - kapsułki twarde - 25 mg
sunitinib sandoz 37,5 mg kapsułki twarde
sandoz gmbh - sunitinibum - kapsułki twarde - 37,5 mg
sunitinib sandoz 50 mg kapsułki twarde
sandoz gmbh - sunitinibum - kapsułki twarde - 50 mg
sunitinib medical valley 12,5 mg kapsułki twarde
medical valley invest ab - sunitinibum - kapsułki twarde - 12,5 mg
sunitinib medical valley 37,5 mg kapsułki twarde
medical valley invest ab - sunitinibum - kapsułki twarde - 37,5 mg
sunitinib medical valley 25 mg kapsułki twarde
medical valley invest ab - sunitinibum - kapsułki twarde - 25 mg
sunitinib medical valley 50 mg kapsułki twarde
medical valley invest ab - sunitinibum - kapsułki twarde - 50 mg
sunitinib bluefish 12,5 mg kapsułki twarde
bluefish pharmaceuticals ab - sunitinibum - kapsułki twarde - 12,5 mg